Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Isabel R. Hsu"'
Autor:
Orison O Woolcott, Joyce M Richey, Morvarid Kabir, Robert H Chow, Malini S Iyer, Erlinda L Kirkman, Darko Stefanovski, Maya Lottati, Stella P Kim, L Nicole Harrison, Viorica Ionut, Dan Zheng, Isabel R Hsu, Karyn J Catalano, Jenny D Chiu, Heather Bradshaw, Qiang Wu, Cathryn M Kolka, Richard N Bergman
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0131033 (2015)
Externí odkaz:
https://doaj.org/article/acd325e4dfb44e77824615af03a18330
Autor:
Orison O Woolcott, Joyce M Richey, Morvarid Kabir, Robert H Chow, Malini S Iyer, Erlinda L Kirkman, Darko Stefanovski, Maya Lottati, Stella P Kim, L Nicole Harrison, Viorica Ionut, Dan Zheng, Isabel R Hsu, Karyn J Catalano, Jenny D Chiu, Heather Bradshaw, Qiang Wu, Cathryn M Kolka, Richard N Bergman
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123558 (2015)
BACKGROUND:Obesity has been associated with elevated plasma anandamide levels. In addition, anandamide has been shown to stimulate insulin secretion in vitro, suggesting that anandamide might be linked to hyperinsulinemia. OBJECTIVE:To determine whet
Externí odkaz:
https://doaj.org/article/a9550449b61140ec87d3e78492fae4f0
Autor:
Darko Stefanovski, Vahe Mooradian, Karyn J. Catalano, Jenny D. Chiu, Stella P. Kim, Justin Dittmann, Dan Zheng, Orison O. Woolcott, Morvarid Kabir, Cathryn M. Kolka, Richard N. Bergman, Gregg W. Van Citters, Sophia Yae, Maya Lottati, Marilyn Ader, Viorica Ionut, Lisa N. Harrison, Huiwen Liu, Katrin Hücking, Joyce M. Richey, Isabel R. Hsu, Martin Ellmerer, Ana Valeria B. Castro
Publikováno v:
Obesity. 22:1238-1245
Objective Insulin resistance is a powerful risk factor for Type 2 diabetes and a constellation of chronic diseases, and is most commonly associated with obesity. We examined if factors other than obesity are more substantial predictors of insulin sen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25b7f067ff6cce01815df43067e4ee65
https://doi.org/10.1002/oby.20625
https://doi.org/10.1002/oby.20625
Autor:
Dan Zheng, Richard N. Bergman, Orison O. Woolcott, Viorica Ionut, Maya Lottati, Darko Stefanoski, Isabel R. Hsu, Morvarid Kabir, Stella P. Kim, Karyn J. Catalano, L. Nicole Harrison, Cathryn M. Kolka, Joyce M. Richey, Jenny D. Chiu
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism. 302:E1261-E1268
The endocannabinoid system is highly implicated in the development of insulin resistance associated with obesity. It has been shown that antagonism of the CB1 receptor improves insulin sensitivity (SI). However, it is unknown whether this improvement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08f8514153d65178253b4096ca3a55c5
https://doi.org/10.1152/ajpendo.00496.2011
https://doi.org/10.1152/ajpendo.00496.2011
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism. 299:E131-E136
Recent studies in animal and human models have revealed that free fatty acid (FFA) release from adipose tissue is oscillatory. We have shown in our laboratory that these oscillations are controlled by the sympathetic nervous system (SNS). Although FF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed89a44332b487a373688d17947df699
https://doi.org/10.1152/ajpendo.00427.2009
https://doi.org/10.1152/ajpendo.00427.2009
Autor:
L. Nicole Harrison, Morvarid Kabir, Darko Stefanovski, Richard N. Bergman, Orison O. Woolcott, Cathryn M. Kolka, Dan Zheng, Viorica Ionut, Vahe Mooradian, Isabel R. Hsu, Stella P. Kim, Maya Lottati, Joyce M. Richey, Karyn J. Catalano, Jenny D. Chiu
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism. 296:E1311-E1318
We investigated whether rimonabant, a type 1 cannabinoid receptor antagonist, reduces visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) in dogs maintained on a hypercaloric high-fat diet (HHFD). To determine whether energy expenditu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::621036c4e09dba952a8e294432e1d5f8
https://doi.org/10.1152/ajpendo.90972.2008
https://doi.org/10.1152/ajpendo.90972.2008
Publikováno v:
Obesity. 15:2416-2423
Objective: Recent studies have shown that free fatty acid (FFA) release is pulsatile and that this pattern is controlled by the sympathetic nervous system. It is, then, necessary to understand and characterize adipose tissue lipolysis to elucidate it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::439aff88371b1f44ffe77c61e128110a
https://doi.org/10.1038/oby.2007.287
https://doi.org/10.1038/oby.2007.287
Publikováno v:
The American Journal of Clinical Nutrition. 86:867S-871S
The term metabolic syndrome describes the association between obesity, insulin resistance, and the risk of several prominent chronic diseases, including cancer. The causal link between many of these components remains unexplained, however. What is cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68e8af56079ebc4dff0371874b396bfd
https://doi.org/10.1093/ajcn/86.3.867s
https://doi.org/10.1093/ajcn/86.3.867s
Autor:
Stella P. Kim, Richard N. Bergman, Marilyn Ader, Jenny D. Chiu, Joyce M. Richey, Isabel R. Hsu, Morvarid Kabir, Karyn J. Catalano
Publikováno v:
The American Journal of Medicine. 120:S3-S8
Visceral adiposity has been identified as an independent risk factor for cardiovascular disease and the so-called metabolic syndrome. The canine obesity model closely recapitulates the correlation between human visceral adiposity and insulin resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbeede36d8a19e2feec0ebf0cf58c8ab
https://doi.org/10.1016/j.amjmed.2006.11.012
https://doi.org/10.1016/j.amjmed.2006.11.012
Autor:
Viorica Ionut, Stella P. Kim, Darko Stefanovski, Morvarid Kabir, Malini S. Iyer, Karyn J. Catalano, Isaac Asare Bediako, Cathryn M. Kolka, Jenny D. Chiu, Orison O. Woolcott, Joyce M. Richey, Isabel R. Hsu, Qiang Wu, Richard N. Bergman
The improvement of hepatic insulin sensitivity by the cannabinoid receptor 1 (CB1R) antagonist rimonabant (RIM) has been recently been reported to be due to upregulation of adiponectin. Several studies demonstrated that improvement in insulin clearan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e184f053515fe73acdb95ad65afc3a0
https://europepmc.org/articles/PMC4609878/
https://europepmc.org/articles/PMC4609878/
